<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02133300</url>
  </required_header>
  <id_info>
    <org_study_id>u0064027</org_study_id>
    <nct_id>NCT02133300</nct_id>
  </id_info>
  <brief_title>NMES in Critically Ill Patients</brief_title>
  <acronym>NESCI</acronym>
  <official_title>Neuromuscular Electrical Stimulation in Critically Ill Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Katholieke Universiteit Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Katholieke Universiteit Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Critically ill patients with a predicted prolonged ICU stay will receive neuromuscular
      electrical stimulation (NMES) of one quadriceps muscle. Whether the dominant or non-dominant
      side will be stimulated is chosen randomly by using opaque sealed envelopes. The patients
      will receive electrical stimulation for 1h for 7 consecutive days. The stimulated and
      non-stimulated side will be compared for it's thickness (by using ultrasound imaging), muscle
      strength if the patients are awake and cooperative (using the medical research council scale
      and handheld dynamometry) and a muscle biopsy will be taken. As a primary outcome the
      investigators hypothesize that electrical stimulation will preserve muscle mass with respect
      to the non-stimulated quadriceps. As secondary outcomes the investigators hypothesize that
      electrical stimulation can reduce muscle strength loss and leads to a better protein balance
      and thicker muscle fibers in the stimulated quadriceps.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Actual">October 2017</completion_date>
  <primary_completion_date type="Actual">October 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Muscle thickness</measure>
    <time_frame>pre-intervention period</time_frame>
    <description>Ultrasound measure in cm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Muscle thickness</measure>
    <time_frame>post intervention period</time_frame>
    <description>Ultrasound measure in cm</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Muscle strength (MRC &amp; HHD)</measure>
    <time_frame>pre intervention period</time_frame>
    <description>MRC: scale HHD: MicroFet, in kg Force</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle fiber thickness</measure>
    <time_frame>post intervention period</time_frame>
    <description>biopsy using Bergström-Stille 5mm needles</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle strength (MRC &amp; HHD)</measure>
    <time_frame>post intervention period</time_frame>
    <description>MRC: scale HHD: MicroFET, in kg Force</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Protein balance</measure>
    <time_frame>post intervention</time_frame>
    <description>biopsy using Bergström-Stille 5mm needles</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Critically Ill Patients With a Predicted Prolonged ICU Stay</condition>
  <arm_group>
    <arm_group_label>electrical stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Compex 3 professional NMES for 60' per day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>electrical stimulation</intervention_name>
    <arm_group_label>electrical stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All adult ICU patients with a predicted prolonged ICU stay

        Exclusion Criteria:

          -  Preexisting neuromuscular disease, polyneuropathy or myopathy (e.g. Guillain-Barré,
             myasthenia gravis, Amyotrophic Lateral Sclerosis, paraplegia, multiple sclerosis, …)

          -  Receiving neuromuscular blocking agents

          -  Musculoskeletal conditions of the pelvis and/or lower limb (e.g. fractures, skin
             disease )

          -  Focal neurological conditions of the pelvis and/or lower limb

          -  Skin disease (e.g. burns)

          -  Presence of a pace-maker or defibrillator

          -  Hemodynamic or Respiratory Instability, active cardiac ischemia

          -  High fever (&gt;39°)

          -  Pregnancy

          -  Brain death

          -  Intracranial pressure &gt;20 mmHg

          -  An anticipated fatal outcome

          -  Psychiatric disorders or severe agitation

          -  Re-admission to the ICU
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>110 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospitals Leuven</name>
      <address>
        <city>Leuven</city>
        <state>Vlaams-Brabant</state>
        <zip>3001</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 6, 2014</study_first_submitted>
  <study_first_submitted_qc>May 6, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 8, 2014</study_first_posted>
  <last_update_submitted>February 20, 2018</last_update_submitted>
  <last_update_submitted_qc>February 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Katholieke Universiteit Leuven</investigator_affiliation>
    <investigator_full_name>Johan Segers</investigator_full_name>
    <investigator_title>M.Sc.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

